| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16fd74f5a5328033eef13db3cb913321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7d0f3daba612e8659b88921a69229af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32f3dfb7d30366e171a57e2bd286e0eb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-30 |
| filingDate |
2003-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62d711bfc9283ae932ca716cbfd30fdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8e1d7c98d1eaf68ca485a92cf4bd790
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_734a7fd05f4b8f8d5ba6570c960c825d |
| publicationDate |
2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005227982-A1 |
| titleOfInvention |
Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin |
| abstract |
Dinitroaniline compounds useful for the treatment of diseases caused by parasitic protozoa in subjects in need of such treatment. The compounds are particularly useful in the treatment of leishmaniasis. The compounds are preferably less cytotoxic to normal cells than oryzalin. Also provided are methods of treating subjects having diseases caused by parasitic protozoa, preferably humans. The method comprising administering a therapeutically effective amount of a dinitroaniline compound of the present invention to a subject in need of such treatment. |
| priorityDate |
2002-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |